News
Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...
GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.
Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes.
A statistically significantly lower risk of dementia or cognitive impairment was observed with GLP-1RAs, though not with SGLT2is or pioglitazone.
The infamous gossip blogger is backing the GLP-1 craze, applauding the celebrities who’ve been candid about their weight loss struggles and their experiences with drugs like Ozempic.
Senator John Fetterman, a democrat from Pennsylvania, admitted to using weight loss drug Mounjaro and issued a desperate plea ...
Senator John Fetterman, a democrat from Pennsylvania, admitted to using weight loss drug Mounjaro and issued a desperate plea ...
A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.
Semaglutide use associated with increased risk for NAION at the 2-, 3-, and 4-year time point from the index date.
Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results